Module 4 - Pharmacology
Module 4 - Pharmacology
Module 4 - Pharmacology
Instruction:
1. Detach one (1) answer sheet from the bottom of your Examinee Answer sheet set
2. :ULWHWKHVXEMHFWWLWOH´PharmacologyµRQWKHER[SURYLGHG
3. 6KDGH6HW%R[´$µRQ\RXUDQVZHUVKHHWLI\RXUWHVWERRNOHWLV6HW$6HW´%µLI\RXUWHVWERRNOet is Set B
9. the plasma, drugs such as phenytoin, salicylates & disopyramide are extensively bound to:
a. Alpha-immunoglobulin d. Gamma-globulin
b. Alpha1-acid glycoprotein e. None of the above
c. Albumin
10. Enzyme induction of a cytochrome P450 enzyme results in
a. Accelerated substrate metabolism
b. Decrease in pharmacologic action of the inducer
c. Decrease in pharmacologic action of the co-administered drug
d. A and B
e. A, B and C
11. The following are established inducers of CYP3A4 isozyme EXCEPT
a. Phenobarbital d. Ketoconazole
b. Rifampin e. None of the above
c. Carbamazepine
12. All of the following are reasons that elderly patients are more susceptible to drug-induced cognitive
changes, EXCEPT:
a. they are more likely to take multiple drugs.
b. they may have hepatic dysfunction.
c. they may have renal dysfunction.
d. they are more sensitive to CNS effects of drugs.
e. they have increased metabolic rates for producing psychoactive metabolites
13. This type of chemical bond is very strong and often results in irreversible receptor binding under biologic
conditions.
a. Hydrogen bond d. Hydrophobic bond
b. Covalent bond e. Electrostatic bond
c. Van del Waals forces
14. A drug that promotes activation of a receptor with 80% Emax is termed a/an
a. Antagonist d. Partial agonist
b. Inverse agonist e. None of the above
c. Full agonist
15. When a weak acid (pKa = 3.9) is exposed to an acidic environment (pH 2), which form of the drug is
predominant?
a. lipid soluble d. A and B
b. hydrophilic e. B and C
c. water soluble
16. Which of the following is an effector molecule for metabotropic receptors?
a. cyclic adenosine monophosphate d. Adenylyl cyclase
b. Inositol triphosphate e. Calcium
c. cyclic guanosine monophosphate
17. The ratio of lipid-soluble form to water-soluble form for a weak acid or a weak base in relation to pH is
expressed by
a. )LFN·V/DZ d. Henderson-Hasselbalch equation
b. Lipid:aqueous partition coefficient e. Michaelis-Menten equation
c. +HQU\·V/DZ
18. The following are sites for drug metabolism
a. Liver d. A, B and C
b. Plasma e. none of the above
c. Intestine
19. This refers to the occurrence of unusual drug response that is infrequently observed in most patients.
a. Hyporeactivity d. Tolerance
b. Idiosyncrasy e. Hyperreactivity
c. Tachyphylaxis
20. Basic signaling mechanism for testosterone, estrogen and other drugs with a steroid nucleus
a. a. interaction with a G-protein coupled receptor
b. interaction with an nuclear receptor
c. interaction with a receptor coupled with an ion channel
d. interaction with a receptor bound to tyrosine kinase
e. none of the above
MODULE 4 - PHARMACOLOGY
21. The following are true about the administration of loading dose
a. Administration of loading dose raises the plasma drug concentration to the target concentration
b. Administration of loading dose is useful for drugs that have long half lives
c. Administration of loading dose is useful for drugs that require a long time to achieve steady state
concentration.
d. For most drugs, the loading dose can be given as a single dose
e. all of the above
22. Which of the following is CORRECT
I. Covalent bonding of one drug with a receptor usually results in reversible
competitive antagonism with another drug
II. Increasing the amount of an agonist would not surmount irreversible competitive
antagonism
III. An antagonist that binds to an allosteric site that inactivates a receptor leads to
non-competitive antagonism with the agonist.
53. AD is a 58 year old male with diabetes, angina and erectile dysfunction. His physician consults the pharmacist in
order to decide if AD would be a good candidate for sildenafil. The use of sildenafil is CONTRAINDICATED for AD
if he takes:
a. isosorbide 5-mononitrate d. ASA
b. metoprolol e. enalapril
c. glyburide
54. A patient with stage I hypertension who has bronchospastic airway disease and who is non-compliant would be
best treated with which of the following beta-blocking agents?
a. timolol d. acebutolol (Sectral®)
b. penbutolol (Levatol®) e. propranolol (Inderal®)
c. esmolol (Brevibloc®)
55. The following agents used in the treatment of heart failure cause positive inotropic effect EXCEPT
a. Dobutamine d. Digoxin
b. Prenalterol e. Inamnirone
c. Propranolol
56. A 65-year-old man presents with stage I hypertension. He has diabetes mellitus and chronic kidney disease and
is intolerant to lisinopril. Which of the following agents would be an appropriate selection for initial treatment in
this patient based on WKHJXLGHOLQHVIURPWKH´(LJKW Report of the Joint National Committee on Detection,
Evaluation, and TreatmenWRI+LJK%ORRG3UHVVXUHµ-1&-8)?
a. chlorothiazide (Various) d. candesartan (Atacand®)
b. propanolol (Inderal®) e. clonidine (Catapres®)
c. nitroprusside (Nitropress®)
57. In an otherwise healthy 50 year old adult with stage I hypertension (BP 145/90 mmHg), recommended initial
antihypertensive therapy would be
I. chlorthalidone (Various)
II. metoprolol (Lopressor®)
III. bisoprolol (Zebeta®)